Академический Документы
Профессиональный Документы
Культура Документы
Nutrition
journal homepage: www.nutritionjrnl.com
a r t i c l e i n f o
a b s t r a c t
Article history:
Received 11 February 2011
Accepted 17 July 2011
Objective: To examine the relation between the Malnutrition Screening Tool (MST) and the
mortality of patients with pulmonary tuberculosis (TB).
Methods: Fifty-two patients with pulmonary TB were analyzed. Nutritional assessment was carried
out using the MST. The MST incorporates three components: presence of weight loss (score 0 or 2),
amount of weight lost (score 14), and poor food intake or poor appetite (score 0 or 1). A score 2
means that the patient is at risk for malnutrition. The Cox proportional hazard model was applied
to assess the ability of the MST to predict prognosis. Receiver operating characteristic curve
analysis was used to assess the MST score as a prognostic indicator in patients with pulmonary TB.
To obtain optimal cutoff values for the MST score for the prognostic assessment in patients with TB,
the maximum Youden index was used.
Results: For predicting the risk of mortality, the optimal cutoff value for the MST score was 2.5.
Univariate and multivariate analyses identied age and a MST score 3 as signicant independent
prognostic factors for survival. The patients with a MST score <3 had a median survival of 453
d and those with a MST score 3 had a median survival of 242 d; the difference was statistically
signicant (P 0.001).
Conclusion: The MST appears to be a reliable tool for the nutritional risk assessment of patients
with pulmonary TB. This risk assessment tool can play a valuable role in quickly identifying
patients at an increased risk of death and providing adequate nutritional support.
2012 Elsevier Inc. All rights reserved.
Keywords:
Malnutrition Screening Tool
Pulmonary tuberculosis
Mortality
Simplicity
Nutritional support
Introduction
Tuberculosis (TB) is a disease with a long history in humans.
TB is also a re-emerging infectious disease that was declared
a global health problem by the World Health Organization in
1993 [1]. There were 9.4 million new TB cases (including 3.3
million women) in 2009, including 1.1 million cases in people
with the human immunodeciency virus. The estimated global
incidence rate decreased to 137 cases per 100 000 people in
2009, after peaking in 2004 at 142 cases per 100 000. The rate is
still decreasing, but too slowly [2]. In Japan, the TB incidence rate
decreased below 20 per 100 000 in 2007 and continued to
decrease, reaching 19.4 in 2008. However, 24 760 patients with
TB were newly identied in 2008. The TB incidence rates in Japan
among the elderly (65 y) were high; for example, 29.5 per 100
000 in those 64 to 74 y old, 64.2 in those 75 to 84 y old, and 97.3
* Corresponding author. Tel.: 81-72-874-1111; fax: 81-72-874-1114.
E-mail address: smiyata61@hotmail.com (S. Miyata).
0899-9007/$ - see front matter 2012 Elsevier Inc. All rights reserved.
doi:10.1016/j.nut.2011.07.013
in those 85 years and older [3]. The aging of the population and
the increased use of immunosuppressive treatments (e.g., cancer
chemotherapy and immunomodulatory agents) highlight the
need for additional strategies to maintain and improve TB
control [4].
Malnutrition is frequently observed in patients with pulmonary TB. Several studies have reported that patients with active
pulmonary TB are malnourished, as indicated by decreases in the
level of visceral proteins, anthropometric indexes, and micronutrient status [5,6]. Nutritional support is necessary for
malnourished patients with TB. Nutritional risk assessment is
important in providing nutritional support.
The Malnutrition Screening Tool (MST) is a simple, quick,
valid, and reliable tool for identifying patients at risk of malnutrition. The tool has only two questions related to weight loss and
decreased appetite. A score of 2 means that the patient is at risk
for malnutrition and warrants further assessment [7].
To the best of our knowledge, no studies have examined the
relation between the MST and the mortality of patients with
272
Anti-TB therapy
All patients received anti-TB therapy. All patients were in-patients at the start
of anti-TB therapy. The regimen consisted of isoniazid, rifampicin, ethambutol,
and pyrazinamide daily for 2 mo, followed by isoniazid and rifampicin daily for
the next 4 mo. The dosages of the anti-TB drugs by body weight are listed in Table
2. Pyrazinamide was not administered to patients 80 y or older. The anti-TB
therapy for patients 80 y or older was carried out for 9 mo.
Nutritional assessment
The nutritional risk assessment was carried out using the MST. It incorporates
three components: the presence of weight loss (score 0 or 2), the amount of
weight lost (score 14), and poor food intake or poor appetite (score 0 or 1). The
total score was calculated for each patient. A score of 2 means that the patient is
at risk for malnutrition. The triceps skinfold thickness was measured with a skin
caliper on the posterior upper arm midway between the acromion and olecranon
processes. A skinfold of 4 to 8 mm suggests borderline fat stores, and a thickness
of 3 mm or less indicates severe depletion. The midarm circumference was
measured using a non-stretch plastic tape midway between the acromion and
olecranon of the non-dominant arm. A measurement of 15 cm or less indicates
severe depletion of muscle mass [8]. Laboratory data including albumin and
lymphocyte count were also collected. Clinical variables were compared by the
risk classes yielded by the MST score.
Statistical analysis
Results are expressed as mean standard deviation. The Cox proportional
hazard model was applied to assess the ability of the MST to predict the
prognosis. Receiver operating characteristic curve analysis was used to assess
the MST score as a prognostic indicator in patients with pulmonary TB. Data
were checked for normality by the ShapiroWilk test and variance homogeneity by the Levene test. Quantitative variables with normal distribution and
homogeneous variances were assessed with the Student t test. Quantitative
variables with normal distribution and inhomogeneous variances were
assessed with the Welch t test. Non-parametric variables were assessed with
the Mann-Whitney U test. Follow-up was measured from the date of the rst
patient visit to the hospital until death or the last date of observation. The
minimum follow-up duration was 90 d. The KaplanMeier method with
the log-rank test was used to calculate survival. P < 0.05 was considered
statistically signicant. Statistical analysis was performed using SPSS 18.0
(SPSS, Inc., Chicago, IL, USA).
Table 2
Dosage of antituberculosis drugs
Body weight
(kg)
Isoniazid
(mg)
Rifampicin
(mg)
Ethambutol
(mg)
Pyrazinamide
(mg)
>3040
>4055
>55
200
300
300
300
450
600
500
750
750
1200
1200
1500
Results
Table 1 presents the demographic and baseline clinical
characteristics of the patients. There were 37 men and 15
women. Their ages ranged from 17 to 98 y (mean SD, 65.9
20.0 y). Univariate and multivariate analyses showed that age
was a signicant prognostic factor. In contrast, an MST score 2
was not a signicant prognostic factor (Table 3). A receiver
operating characteristic curve was generated for further analysis
of the prognostic value of the MST score, as presented in Figure 1.
The area under the curve was 0.78 (95% condence interval [CI]
0.6490.911). The MST score was considered to have moderate
prognostic accuracy. To obtain optimal cutoff values for the MST
score for the prognostic assessment in patients with TB, we used
the maximum Youden index. For predicting the risk of mortality,
the optimal cutoff value for an MST score was 2.5. Using a cutoff
value for an MST score of 2.5, the sensitivity was 75.0% and the
specicity was 77.5% for survival. Patients were divided into two
groups based on their MST score (<3 or 3). Based on this cutoff
value, the Cox proportional hazard model was applied to assess
the ability of an MST score 3 to predict the prognosis of patients
with TB. Univariate analysis showed that age and an MST score
3 were signicant prognostic factors (Table 4). Multivariate
analysis identied age (hazard ratio 1.067, 95% CI 1.0151.122, P
0.012) and an MST score 3 (hazard ratio 4.073, 95% CI 1.026
16.178, P 0.046) as signicant independent prognostic factors
for survival. The characteristics of the study population according to the MST score using 2.5 as the cutoff value are presented in
Table 5. The midarm circumference was signicantly larger in the
patients with an MST score <3 (21.9 3.2) than in the patients
with an MST score 3 (18.5 2.3, P < 0.001). Similarly, body
mass index, triceps skinfold thickness, serum albumin, blood
lymphocyte count, and hemoglobin were signicantly higher in
the patients with an MST score <3 than in the patients with an
MST score 3. Higher C-reactive protein concentrations were
observed in the patients with an MST score 3 (Table 5). Figure 2
shows the survival curves for the patients with an MST score <3
and those with an MST score 3. The patients with an MST score
<3 had a median survival of 453 d (95% CI 407499) and those
with an MST score 3 had a median survival of 242 d (95% CI
151332); the difference was statistically signicant (P 0.001).
Discussion
Table 1
Characteristics of 52 patients with pulmonary tuberculosis
Variables
All patients
Men/women
Age (y)
Weight (kg)
Body mass index (kg/m2)
Midarm circumference (cm)
Triceps skinfold thickness (mm)
Serum albumin (g/dL)
Blood lymphocyte count (cells/mL)
Hemoglobin (g/dL)
C-reactive protein (mg/dL)
37/15
65.9
49.6
18.7
20.8
5.5
3.0
979
11.6
6.4
20.0
11.1
3.0
3.3
3.0
0.9
582
2.3
6.1
Age
MST 2
Univariate analysis
Multivariate analysis
HR
95% CI
HR
95% CI
1.09
7.102
1.0301.154
0.91655.067
0.003
0.061
1.084
3.511
1.0251.147
0.44627.650
0.005
0.233
CI, condence interval; HR, hazard ratio; MST, Malnutrition Screening Tool
273
Table 5
Characteristics of the study population by MST score
Variables
Age (y)
Weight (kg)
Body mass index (kg/m2)
Midarm circumference (cm)
Triceps skinfold thickness (mm)
Serum albumin (g/dL)
Blood lymphocyte count (cells/mL)
Hemoglobin (g/dL)
CRP (mg/dL)
MST <3
MST 3
(n 34)
(n 18)
62.6
52.0
19.3
21.9
6.2
3.3
1142
12.2
5.5
20.0
11.8
3.1
3.2
3.1
0.8
641
2.4
6.0
72.2
45.0
17.5
18.5
4.2
2.4
670
10.6
8.5
19.1
7.9
2.7
2.3
2.3
0.5
254
1.5
5.9
0.083
0.043
0.038
<0.001
0.016
<0.001
<0.001
0.019
0.03
Fig. 1. Receiver operating characteristic curve for the Malnutrition Screening Tool
score (n 52, area under the curve 0.780, 95% condence interval 0.6490.911).
Table 4
Cox proportional hazard regression analyses of age and MST score 3 associated
with survival
Variables
Age
MST 3
Univariate analysis
Multivariate analysis
HR
95% CI
HR
95% CI
1.09
6.504
1.0301.154
1.75524.104
0.003
0.005
1.067
4.073
1.0151.122
1.02616.178
0.012
0.046
CI, condence interval; HR, hazard ratio; MST, Malnutrition Screening Tool
Fig. 2. Survival curves for the patients with an MST score <3 and those with an
MST score 3. Censored patients were those who reached the end of their followup without dying (P 0.001, log-rank test). MST, Malnutrition Screening Tool.
274
[9] van Lettow M, Fawzi WW, Semba RD. Triple trouble: the role of malnutrition in tuberculosis and human immunodeciency virus co-infection.
Nutr Rev 2003;61:8190.
[10] Villamor E, Fawzi WW. Effects of vitamin A supplementation on immune
responses and correlation with clinical outcomes. Clin Microbiol Rev
2005;18:44664.
[11] Webb AL, Villamor E. Update: effects of antioxidant and non-antioxidant
vitamin supplementation on immune function. Nutr Rev 2007;65:181217.
[12] Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A, et al.
Inuence of vitamin D deciency and vitamin D receptor polymorphisms
on tuberculosis among Gujarati Asians in west London: a casecontrol
study. Lancet 2000;355:61821.
[13] Davies PD, Brown RC, Woodhead JS. Serum concentrations of vitamin D
metabolites in untreated tuberculosis. Thorax 1985;40:18790.
[14] Davies PD, Church HA, Brown RC, Woodhead JS. Raised serum calcium in
tuberculosis patients in Africa. Eur J Respir Dis 1987;71:3414.
[15] Sasidharan PK, Rajeev E, Vijayakumari V. Tuberculosis and vitamin D
deciency. J Assoc Phys India 2002;50:5548.
[16] Fantuzzi G. Adipose tissue, adipokines, and inammation. J Allergy Clin
Immunol 2005;115:9119.
[17] Faggioni R, Feingold KR, Grunfeld C. Leptin regulation of the immune
response and the immunodeciency of malnutrition. FASEB J
2001;15:256571.
[18] Schwenk A, Hodgson L, Rayner CF, Grifn GE, Macallan DC. Leptin
and energy metabolism in pulmonary tuberculosis. Am J Clin Nutr
2003;77:3928.
[19] van Lettow M, van der Meer JW, West CE, van Crevel R, Semba RD. Interleukin-6 and human immunodeciency virus load, but not plasma leptin
concentration, predict anorexia and wasting in adults with pulmonary
tuberculosis in Malawi. J Clin Endocrinol Metab 2005;90:47716.
[20] Wieland CW, Florquin S, Chan ED, Leemans JC, Weijer S, Verbon A, et al.
Pulmonary Mycobacterium tuberculosis infection in leptin-decient ob/ob
mice. Int Immunol 2005;17:1399408.
[21] Joosten KF, Hulst JM. Malnutrition in pediatric hospital patients. Nutrition
2011;27:1337.
[22] Hulst JM, Zwart H, Hop WC, Joosten KF. Dutch national survey to test the
STRONG(kids) nutritional risk screening tool in hospitalized children. Clin
Nutr 2010;29:10611.
[23] Raguso CA, Luthy C. Nutritional status in chronic obstructive pulmonary
disease: role of hypoxia. Nutrition 2011;27:13843.
[24] Hallin R, Gudmundsson G, Suppli Ulrik C, Nieminen MM, Gislason T,
Lindberg E, et al. Nutritional status and long-term mortality in hospitalized
patients with chronic obstructive pulmonary disease (COPD). Respir Med
2007;101:195460.
[25] Ferguson ML, Bauer J, Gallagher B, Capra S, Christie DR, Mason BR. Validation of a malnutrition screening tool for patients receiving radiotherapy.
Australas Radiol 1999;43:3257.
[26] Isenring E, Cross G, Daniels L, Kellett E, Koczwara B. Validity of the
malnutrition screening tool as an effective predictor of nutritional risk in
oncology outpatients receiving chemotherapy. Support Care Cancer
2006;14:11526.
[27] Vivanti AP, McDonald CK, Palmer MA, Sinnott M. Malnutrition associated
with increased risk of frail mechanical falls among older people presenting
to an emergency department. Emerg Med Australas 2009;21:38694.
[28] Isenring EA, Bauer JD, Banks M, Gaskill D. The Malnutrition Screening Tool
is a useful tool for identifying malnutrition risk in residential aged care.
J Hum Nutr Diet 2009;22:54550.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.